U.S. Moves to Block Shipments From Chinese Genomics Firm BGI Over Forced Labor Allegations

The Trump administration said Wednesday that it is blocking shipments from the Chinese biotech company BGI Group and its affiliates, alleging ties to forced labor in China's far-western Xinjiang region. Starting Thursday, U.S. Customs and Border Protection will bar goods from the companies. The Department of Homeland Security has added three major Chinese genomics companies to the Uyghur Forced Labor Prevention Act Entity List. U.S. officials allege that BGI is associated with forced labor and the abuse of minority groups, and the move will block shipments from the firm. The action covers three Chinese biotech companies in total, and the restrictions begin Thursday.

Left-leaning sources, represented by The New York Times, lead with the trade restriction under the headline "U.S. Restricts Trade With Chinese Genomics Company," focusing on BGI and officials' allegations of abuse of minority groups; its excerpt does not mention the three-company count or the list designation. Right-leaning sources, represented by The Washington Times, lead with the Department of Homeland Security adding three companies to the Uyghur Forced Labor Prevention Act Entity List, centering the story on a government list. Alternative sources, represented by the AP, attribute the decision to the Trump administration, cite the Wednesday announcement and the Thursday start for Customs and Border Protection, and headline three Chinese biotech companies facing import bans. All three agree that shipments are being blocked over forced labor allegations involving BGI. They differ on which government body acts, whether the emphasis falls on one company or three, and whether the story centers on a trade restriction or a list addition.